Tag: Medical Research

kevin-hall-top-nh-nutrition-scientist-unlikely-to-return-to-agency

Kevin Hall, Top NIH Nutrition Scientist, Unlikely to Return to Agency

Kevin Hall, a top nutrition scientist who recently left the National Institutes of Health, revealed that he probably won't be making a comeback to...
summit-therapeutics-clinical-trial-update-what-you-need-to-know

Summit Therapeutics Clinical Trial Update: What You Need to Know

Adam Feuerstein, a seasoned writer and biotech columnist, dives into the world of drug development, business, Wall Street, and biotechnology. He wears many hats...
fight-for-your-science-aacr-cancer-researchers-urgent-call

Fight for Your Science: AACR Cancer Researchers’ Urgent Call

So, like, this dude Angus Chen, right? He's all about cancer stuff - drugs, policy, science, equity, you name it. He hopped on board...
bhattacharya-nears-confirmation-as-nh-director

Bhattacharya Nears Confirmation as NIH Director

Jay Bhattacharya, the nominee for the position of Director of the National Institutes of Health, faced a confirmation hearing on Wednesday that left many...
1984-tribute-to-nh-valuable-nsights-for-todays-physicians

1984 Tribute to NIH: Valuable Insights for Today’s Physicians

In a world where the National Institutes of Health (NIH) announced drastic cuts to indirect costs, the implications for research, innovation, and healthcare are...
mpact-of-trump-administration-health-research-cuts-on-massachusetts

Impact of Trump Administration Health Research Cuts on Massachusetts

Amidst the bustling streets of Massachusetts, a looming shadow of uncertainty falls upon the biomedical research community. Elected leaders, including Senator Ed Markey, have...
first-n-vivo-beta-thalassemia-trial-by-chinese-biotech-what-to-expect

First In Vivo Beta-Thalassemia Trial by Chinese Biotech: What to Expect

First In Vivo Beta-Thalassemia Trial by Chinese Biotech: A Groundbreaking Leap in Genetic MedicineIn a groundbreaking move that could revolutionize genetic medicine, Chinese biotech...
exploring-the-benefits-and-risks-of-glp-1s-a-comprehensive-study

Exploring the Benefits and Risks of GLP-1s: A Comprehensive Study

GLP-1 Drugs Unveiled: Promises and Pitfalls RevealedIn a groundbreaking study published in Nature Medicine on Monday, clinical epidemiologist and nephrologist Ziyad Al-Aly from Washington...
navigating-pharmas-patent-cliff-mpact-on-obesity-fundraising-and-als-research

Navigating Pharma’s Patent Cliff: Impact on Obesity Fundraising and ALS Research

Navigating Pharma's Patent Cliff: Impact on Obesity Fundraising and ALS ResearchIn the fast-paced world of biotech, the looming patent cliff is causing a stir...
lung-cancer-drug-by-johnson-johnson-boosts-survival-rate

Lung Cancer Drug by Johnson & Johnson Boosts Survival Rate

Johnson & Johnson's Breakthrough Lung Cancer Drug Shows Promise in Boosting Survival RatesIn a groundbreaking development in the fight against non-small cell lung cancer,...
revolutionary-biotech-battle-mpact-on-transplants-in-mantle-cell-lymphoma

Revolutionary Biotech Battle: Impact on Transplants in Mantle Cell Lymphoma

Revolutionary Biotech Battle: Impact on Transplants in Mantle Cell LymphomaIn a groundbreaking showdown at the ASH 2024 conference, the biotech world witnessed an intense...
news-12112024-041658

Ending 23andMe’s Drug Discovery Dream: What Went Wrong?

23andMe, the genetics company that many people have been excited about, recently made a big announcement. The company has decided to stop working on...

BREAKING NEWS

Top News